77.40
0.74 (0.97%)
0.74 (0.97%)
Upgrade to Real-Time
Afterhours (Closed)
Low
71.715
High
87.80
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.74 | 0.97% | 77.40 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 76.92 | 76.815 | 77.75 | 77.47 | 76.66 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 76,746 | 11,937,011 | $ 77.27 | $ 922,430,006 | 9,651,539 | 71.715 - 87.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:07 | 20 | $ 77.48 | USD |
Merck Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 195.82B | 2.53B | 2.53B | $ 46.84B | $ 12.11B | 3.81 | 17.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 2.26 | 2.92% | - | - |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 75.51 | 77.75 | 75.425 | 76.43 | 9,487,033 | 1.89 | 2.5% |
| 1 Month | 77.31 | 78.545 | 75.28 | 76.83 | 12,397,163 | 0.09 | 0.12% |
| 3 Months | 81.12 | 81.43 | 71.715 | 75.90 | 12,160,308 | -3.72 | -4.59% |
| 6 Months | 79.30 | 85.60 | 71.715 | 78.06 | 10,432,530 | -1.90 | -2.4% |
| 1 Year | 82.96 | 87.80 | 71.715 | 79.15 | 9,788,076 | -5.56 | -6.7% |
| 3 Years | 57.77 | 92.64 | 56.255 | 77.44 | 10,062,661 | 19.63 | 33.98% |
| 5 Years | 56.11 | 92.64 | 52.83 | 70.93 | 9,733,852 | 21.29 | 37.94% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States. |
